Submitted by Anonymous (not verified) on 16 January 2026 - 13:50
Human medicines European public assessment report (EPAR): Amyvid, florbetapir (18F), Date of authorisation: 14/01/2013, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Amyvid, florbetapir (18F), Date of authorisation: 14/01/2013, Revision: 16, Status: Authorised